Literature DB >> 9114050

A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1.

E M Ruaro1, L Collavin, G Del Sal, R Haffner, M Oren, A J Levine, C Schneider.   

Abstract

The involvement of p53 in regulating diverse cellular processes dictates that it must respond to multiple signaling mechanisms, thus coordinating the response to various "stress conditions." Genotoxic stress has served as a paradigm to dissect the transactivation-dependent branch of the pathway by which p53 can induce growth arrest. Alternate mechanisms have been invoked to explain transactivation-independent effects of p53, especially in the context of apoptosis. We have identified a p53-dependent pathway initiated by the gas1 product, a plasma membrane protein highly expressed during G0, which activates a transactivation-independent p53 growth arrest function. Through a detailed deletional analysis and site-specific mutagenesis of p53 we show that the Gas1-dependent signal transduction relies on a proline-rich region (amino acids 63-85) of murine p53. In vivo competition experiments using combinations of such mutants implicate this functional domain of p53 as a docking site in the transmission of antiproliferative signals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114050      PMCID: PMC20783          DOI: 10.1073/pnas.94.9.4675

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  The growth arrest-specific gene, gas1, is involved in growth suppression.

Authors:  G Del Sal; M E Ruaro; L Philipson; C Schneider
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

2.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 3.  Structural aspects of the p53 protein in relation to gene evolution.

Authors:  T Soussi; C Caron de Fromentel; P May
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

4.  Identification of a novel p53 functional domain that is necessary for efficient growth suppression.

Authors:  K K Walker; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

Review 6.  The tumor suppressor genes.

Authors:  A J Levine
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

7.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

8.  Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity.

Authors:  M Tarunina; J R Jenkins
Journal:  Oncogene       Date:  1993-11       Impact factor: 9.867

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation.

Authors:  E Shaulian; A Zauberman; J Milner; E A Davies; M Oren
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  22 in total

Review 1.  Regulation of p53 and its targets during involution of the mammary gland.

Authors:  D J Jerry; J Pinkas; C Kuperwasser; E S Dickinson; S P Naber
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.

Authors:  Shih-Shun Chen; Pi-Chu Chang; Yu-Wen Cheng; Fen-Mei Tang; Young-Sun Lin
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Authors:  C Venot; M Maratrat; C Dureuil; E Conseiller; L Bracco; L Debussche
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

5.  p53 protein is a suppressor of papillomavirus DNA amplificational replication.

Authors:  D Lepik; I Ilves; A Kristjuhan; T Maimets; M Ustav
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 6.  Cell cycle exit: growth arrest, apoptosis, and tumor suppression revisited.

Authors:  L Philipson
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

7.  Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.

Authors:  B F Müller-Tiemann; T D Halazonetis; J J Elting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Myc represses transcription of the growth arrest gene gas1.

Authors:  T C Lee; L Li; L Philipson; E B Ziff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

9.  HNCA-TOCSY-CANH experiments with alternate (13)C- (12)C labeling: a set of 3D experiment with unique supra-sequential information for mainchain resonance assignment.

Authors:  Koh Takeuchi; Maayan Gal; Hideo Takahashi; Ichio Shimada; Gerhard Wagner
Journal:  J Biomol NMR       Date:  2010-11-26       Impact factor: 2.835

Review 10.  Growth arrest specific gene 1: a fuel for driving growth in the cerebellum.

Authors:  Gregory Marques; Chen-Ming Fan
Journal:  Cerebellum       Date:  2002-12       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.